PainReform Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	3.55	4.45	4.35	1.32	0.55	0.28
Research & Development	6.04	4.42	2.86	0.35	0.14	0.22
Operating Expenses	9.58	8.87	7.21	1.67	0.69	0.5
Operating Income	-9.58	-8.87	-7.21	-1.67	-0.69	-0.5
Interest Expense / Income	-0.25	-0.09	0.03	0.99	0.59	0.33
Other Expense / Income	-	-	-	1.18	-	-
Pretax Income	-9.34	-8.78	-7.24	-3.83	-1.28	-0.83
Income Tax	0.01	0.01	0.01	0.22	0	0
Net Income	-9.34	-8.79	-7.25	-4.05	-1.28	-0.83
Shares Outstanding (Basic)	1	1	1	0	0	0
Shares Outstanding (Diluted)	1	1	1	0	0	0
Shares Change	21.00%	8.22%	208.13%	462.64%	-	-
EPS (Basic)	-7.14	-8.13	-7.25	-12.50	-41.70	-32.40
EPS (Diluted)	-7.14	-8.13	-7.25	-12.50	-41.70	-32.40
Free Cash Flow	-6.69	-6.47	-6.6	-2.57	-0.61	-0.64
Free Cash Flow Per Share	-5.11	-5.98	-6.61	-7.91	-10.56	-11.01
EBITDA	-9.57	-8.85	-7.2	-2.85	-0.69	-0.5
Depreciation & Amortization	0.02	0.02	0.01	0	0	0
EBIT	-9.58	-8.87	-7.21	-2.85	-0.69	-0.5

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).